MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY

被引:1250
作者
BARAK, Y
JUVEN, T
HAFFNER, R
OREN, M
机构
[1] Department of Chemical Immunology, The Weizmann Institute of Science
关键词
GROWTH CONTROL; MDM2; P53; TUMOR SUPPRESSOR;
D O I
10.1002/j.1460-2075.1993.tb05678.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have recently characterized a 95 kDa protein, p95, which exhibits enhanced binding to temperature-sensitive p53 (ts-p53) when cells are shifted down to 32.5-degrees-C, a temperature at which ts-p53 possesses wild-type (wt)-like activities. In the present study we show that p95 is a product of the mdm2 putative proto-oncogene. The enhanced complex formation of mdm2 with ts-p53 in cells maintained at 32.5-degrees-C is due to an elevation in total mdm2 protein levels following the temperature shift. We further demonstrate that the induction of mdm2 expression by wt p53 activity is at the mRNA level. The induction occurs with very rapid kinetics and does not require de novo protein synthesis, suggesting a direct involvement of p53 in the process. Based on these data and on recent findings implicating p53 as a transcription factor, we suggest that the mdm2 gene is a target for activation by wt p53. In view of the ability of mdm2 to act as a specific antagonist of p53 activity, this induction process may serve to tightly autoregulate p53 activity in living cells.
引用
收藏
页码:461 / 468
页数:8
相关论文
共 62 条
[1]   CLONING AND SEQUENCE OF THE HUMAN NUCLEAR-PROTEIN CYCLIN - HOMOLOGY WITH DNA-BINDING PROTEINS [J].
ALMENDRAL, JM ;
HUEBSCH, D ;
BLUNDELL, PA ;
MACDONALDBRAVO, H ;
BRAVO, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (06) :1575-1579
[2]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[3]   ENHANCED BINDING OF A 95-KDA PROTEIN TO P53 IN CELLS UNDERGOING P53-MEDIATED GROWTH ARREST [J].
BARAK, Y ;
OREN, M .
EMBO JOURNAL, 1992, 11 (06) :2115-2121
[4]   WILD-TYPE BUT NOT MUTANT P53 IMMUNOPURIFIED PROTEINS BIND TO SEQUENCES ADJACENT TO THE SV40 ORIGIN OF REPLICATION [J].
BARGONETTI, J ;
FRIEDMAN, PN ;
KERN, SE ;
VOGELSTEIN, B ;
PRIVES, C .
CELL, 1991, 65 (06) :1083-1091
[5]   SEQUENCE OF THE MURINE AND HUMAN CELLULAR MYC ONCOGENES AND 2 MODES OF MYC TRANSCRIPTION RESULTING FROM CHROMOSOME-TRANSLOCATION IN B-LYMPHOID TUMORS [J].
BERNARD, O ;
CORY, S ;
GERONDAKIS, S ;
WEBB, E ;
ADAMS, JM .
EMBO JOURNAL, 1983, 2 (12) :2375-2383
[6]   MODULATION OF ACTIVITY OF THE PROMOTER OF THE HUMAN MDR1 GENE BY RAS AND P53 [J].
CHIN, KV ;
UEDA, K ;
PASTAN, I ;
GOTTESMAN, MM .
SCIENCE, 1992, 255 (5043) :459-462
[7]   PERMANENT EXPRESSION OF P53 IN FR-3T3 RAT-CELLS BY CELL CYCLE-DEPENDENT ASSOCIATION WITH LARGE-T-ANTIGEN IN SIMIAN VIRUS-40 TRANSFORMANTS [J].
COULIER, F ;
IMBERT, J ;
ALBERT, J ;
JEUNET, E ;
LAWRENCE, JJ ;
CRAWFORD, L ;
BIRG, F .
EMBO JOURNAL, 1985, 4 (13A) :3413-3418
[8]   P53 FUNCTIONS AS A CELL-CYCLE CONTROL PROTEIN IN OSTEOSARCOMAS [J].
DILLER, L ;
KASSEL, J ;
NELSON, CE ;
GRYKA, MA ;
LITWAK, G ;
GEBHARDT, M ;
BRESSAC, B ;
OZTURK, M ;
BAKER, SJ ;
VOGELSTEIN, B ;
FRIEND, SH .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) :5772-5781
[9]   POST-TRANSCRIPTIONAL CONTROL OF MYC AND P53 EXPRESSION DURING DIFFERENTIATION OF THE EMBRYONAL CARCINOMA CELL LINE-F9 [J].
DONY, C ;
KESSEL, M ;
GRUSS, P .
NATURE, 1985, 317 (6038) :636-639
[10]   DEFINITION OF A CONSENSUS BINDING-SITE FOR P53 [J].
ELDEIRY, WS ;
KERN, SE ;
PIETENPOL, JA ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE GENETICS, 1992, 1 (01) :45-49